Thursday announced the acquisition of Xbrane Biopharma AB’s R&D operations and a biosimilar candidate, establishing a footprint in the Swedish life science sector. The acquisition’s purchase price ...

Alvo Minerals pens non-binding LOI with Pan American Silver for Lavra Velha gold-copper project in Brazil. With high gold ...

It's been a mediocre week for Alvotech ( NASDAQ:ALVO ) shareholders, with the stock dropping 17% to US$9.55 in the ...

In trading on Friday, shares of Alvotech (Symbol: ALVO) entered into oversold territory, hitting an RSI reading of 24.4, after changing hands as low as $9.60 per share. By comparison, the current ...

Northland Securities analyst Carl Byrnes maintained a Buy rating on Alvotech (ALVO – Research Report) today and set a price target of $28.00.

The project is considered an Iron Oxide Copper Gold (IOCG) style deposit, exhibiting shallow, high-grade gold and silver intersections, and significant copper and silver intercepts at depth.

Alvo Minerals (ASX:ALV) has seen its share price spike more than 16% on news it is acquiring a 520,000-ounce gold project in ...

Alvotech (NASDAQ:ALVO – Get Free Report) is expected to issue its quarterly earnings data after the market closes on ...

Good day and thank you for standing by. Welcome to the Alvotech Q4 2024 earnings call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Alvotech acquires Xbrane's R&D operations and biosimilar candidate for SEK 275 million, enhancing development capabilities ...

Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.